Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles N Ellis

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of the American Academy of Dermatology|October 22, 2021
Epicardial adipose tissue volume is greater in men with severe psoriasis, implying an increased cardiovascular disease risk: A cross-sectional studyCharles N Ellis, Stephen J Neville, Mohamed Sayyouh, et al.
Archives of Dermatological Research|June 29, 2004
Alpha-Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseasesMeenakshi S Venkatraman, Amar Chittiboyina, Josef Meingassner, et al.
Journal of the American Academy of Dermatology|May 19, 2016
OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled studyJon M Hanifin, Charles N Ellis, Ilona J Frieden, et al.
Pharmacoeconomics|August 12, 2003
Validation of expert opinion in identifying comorbidities associated with atopic dermatitis/eczemaCharles N Ellis, Lynn A Drake, Mary M Prendergast, et al.
The Journal of Investigative Dermatology|February 14, 2004
Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytesNarasimharao Bhagavathula, Kamalakar C Nerusu, Ashish Lal, et al.
Journal of the American Academy of Dermatology|March 29, 2003
Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitisCharles N Ellis, Lynn A Drake, Mary M Prendergast, et al.
Journal of the American Academy of Dermatology|February 28, 2002
Cost of atopic dermatitis and eczema in the United StatesCharles N Ellis, Lynn A Drake, Mary M Prendergast, et al.
Dermatology and Therapy|December 23, 2018
Clinical Goals and Barriers to Effective Psoriasis CareBruce E Strober, Joelle M van der Walt, April W Armstrong, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of the American Academy of Dermatology|October 22, 2021
Epicardial adipose tissue volume is greater in men with severe psoriasis, implying an increased cardiovascular disease risk: A cross-sectional studyCharles N Ellis, Stephen J Neville, Mohamed Sayyouh, et al.
Archives of Dermatological Research|June 29, 2004
Alpha-Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseasesMeenakshi S Venkatraman, Amar Chittiboyina, Josef Meingassner, et al.
Journal of the American Academy of Dermatology|May 19, 2016
OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled studyJon M Hanifin, Charles N Ellis, Ilona J Frieden, et al.
Pharmacoeconomics|August 12, 2003
Validation of expert opinion in identifying comorbidities associated with atopic dermatitis/eczemaCharles N Ellis, Lynn A Drake, Mary M Prendergast, et al.
The Journal of Investigative Dermatology|February 14, 2004
Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytesNarasimharao Bhagavathula, Kamalakar C Nerusu, Ashish Lal, et al.
Journal of the American Academy of Dermatology|March 29, 2003
Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitisCharles N Ellis, Lynn A Drake, Mary M Prendergast, et al.
Journal of the American Academy of Dermatology|February 28, 2002
Cost of atopic dermatitis and eczema in the United StatesCharles N Ellis, Lynn A Drake, Mary M Prendergast, et al.
Dermatology and Therapy|December 23, 2018
Clinical Goals and Barriers to Effective Psoriasis CareBruce E Strober, Joelle M van der Walt, April W Armstrong, et al.
Pageof 5